OCT CLINICAL TRIALS IN EASTERN EUROPE

Our value

We have been conducting full service projects in Eastern Europe and CIS since 2005

Thorough local expertise

• 14+ years of experience in the industry
• Risk-management approach
• 300 projects in portfolio
• A team of 200 professionals

Global sponsors

• Extensive project portfolio with sponsors from EU, US, CIS and Asia
• Successfully passed more than 60 audits by sponsors with no significant findings

Record-setting patient enrollment

• Access to the network of 1600+ leading scientific sites
• Extensive experience in fast enrollment of patients with different indications

Quality

• FDA/EMA acceptable data
• Compliance with the international standards (ICH GCP), local regulatory requirements and internal SOPs

News

all news

Jul

FIRST PATIENTS HAVE BEEN ENROLLED IN TWO CLINICAL STUDIES IN HEMORRHOIDS

OCT has successfully initiated patient recruitment for the phase III clinical trials in hemorrhoids in Russia. Within the project OCT will be running two studies: one with the suppository therapy, and the other where the subjects will undergo a rectal cream treatment. As of now, first subjects have been enrolled in both trials.

read

Enrollment target reached: 1030 patients for a phase III erectile disfunction study in 4 countries

OCT team has successfully completed recruitment of 1030 subjects for a phase III study of a drug for male erectile dysfunction. The study is running in Russia, Bulgaria, Ukraine and Latvia.

read

Jun

What did you miss at ASCO? Quick overview by OCT

For years ASCO, the world's leading clinical oncology annual meeting, has been a highlight in the biopharma calendar for professionals researching treatment methods. And this one was no different. Why? The pace of cancer research is so dynamic, that even within a span of one year a lot happens.

read

[Webinar] Why do US sponsors conduct clinical trials in Russia?

Find out why more than 50% of studies initiated in Russia are conducted by foreign sponsors with the US in the lead. Key experts from one of the major local CROs in Eastern Europe will share exclusive insights on 3 critical benefits of the region to advance your clinical strategy.

read